Placeholder

Reaching The Higher Ground Through Higher Education

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1497. Categories: , .

Product Description

    With the economy in turmoil and job cuts at the highest level since 2002, the pharmaceutical industry is under extreme pressures — layoffs, increased regulatory scrutiny, generic competition, pricing constraints, escalating R&D costs, etc. To thrive, no less survive, in these trying times, companies need leadership from their best and brightest employees to find solutions to these and future challenges.
    One way industry leaders can stay relevant and provide value to their companies while boosting their credentials is through graduate education.
    “In tight economic times, one would expect that fewer people would be interested in graduate education because of the expense, but the reality is that employees know that better credentials are important, especially when companies are looking to downsize,” says David Brushwood, R.Ph., J.D., professor of pharmaceutical outcomes and policy at the University of Florida. “People are looking for ways to add to their credentials so they will continue…

Sidebar:
Tips for Managing in a Bad Economy

Experts on this topic
David B. Brushwood, R.Ph., J.D.
Professor of Pharmaceutical Outcomes and Policy, University of Florida, one of the nation’s five largest universities, and a major public land-grant research institution. For more information, visit ufl.edu.
Terry Hisey. Vice Chairman and U.S. Industry Leader, Life Sciences, Deloitte LLP, which provides audit, consulting, financial advisory, risk management, and tax services. For more information, visit deloitte.com.
Joseph P. Pieroni. President and CEO, Daiichi Sankyo Inc., the U.S. subsidiary of Tokyo-based global research
pharmaceutical company, Daiichi Sankyo Co. Ltd. For more information, visit dsus.com.
Ted Surynt, Ph.D. Associate Dean of the School of Business, Stetson University, whose undergraduate as well as graduate programs include education, counseling, business, law, and English. For more information, visit stetson.edu/business.
Larry Van Horn. Associate Professor of Management and Faculty Director, Healthcare MBA Program, Vanderbilt University, Owen Graduate School of Management, one of the world’s top business schools. For more information, visit owen.vanderbilt.edu.
Terese Waldron. Director of Executive MBA and Executive Pharmaceutical Marketing Programs, Saint Joseph’s University, a Jesuit university with executive MBA programs dedicated to the pharma industry, other executive MBA, MBA, and masters business programs, and graduate and undergraduate programs. For more information, visit sju.edu.

FEEDBACK